Sarepta Announces Date for SRP-9001 FDA Advisory Committee Meeting: Make Your Voice Heard on May 12th ...
Leveraging Our United Voices: A Call To Collaborative Action Ahead of FDA’s Advisory Committee for SRP-9001 ...
PPMD Announces Cardiac Care Workshop Report, Advancing Understanding of Heart Disease in Duchenne ...
WATCH: Viltepso, An FDA-Approved Treatment for Patients Amenable to Exon 53 Skipping – Webinar Recording ...